Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing cardiac myosin function and availability. As such, it is positioned as a ...

Results demonstrate that DIAG723, the Company's lead clustering antibody, can prevent PAH, offering the potential as a first-in-class PAH treatment ...

Vyommitra has smart AI technology inside it, which allows it to think and respond like a human during the mission. It can ...